Hypertension and Heart Failure: Role of Neurohormonal Mechanisms

References

• Kannel W B, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72(suppl)S3–S9, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• The task force for the diagnosis and treatment of chronic heart failure, European Society of cardiology. Eur Heart J 2001; 22: 1527–1560, [CROSSREF]
   Google Scholar
• Francis G S, Rector T S, Cohn J N. Sequential neurohumoral measurements in patients with congestive heart failure. Am Heart J 1988; 116: 1464–1468, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Schrier R W, Abraham W T. Hormones and haemodynamics in heart failure. N Engl J Med 1999; 341: 577–585, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kjær B, Hesse. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001; 21(6)661–672, [CROSSREF]
   Google Scholar
• The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1991; 327: 1667, [CSA]
   Google Scholar
• The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293–302
   Google Scholar
• Pfeffer M A, Braunwald E, Moye L A, Basta L, Brown E J, Jr, Cuddy T E, Davis B R, Geltman E M, Goldman S, Flaker G C, The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669–677, [PUBMED], [INFOTRIEVE]
   Google Scholar
• The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385–1390, [CROSSREF]
   Google Scholar
• Pitt B, Zannad F, Remme W J, Cody R, Castaigne A, Perez A, Palensky J, Wittes for the Randomized Aldactone Evaluation Study Investigators (RALES) J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709–717, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Pitt B, Poole‐Wilson P A, Segal R, Martinez F A, Dickstein K, Camm A J, Konstam M A, Riegger G, Klinger G H, Neaton J, Sharma D, Thiyagarajan B, on behalf of the The Losartan Heart Failure Survival Study (ELITE II) Investigators. Effect of Losartan compared with Captopril on mortality in patients with symptomatic heart failure: a randomized trial. Lancet 2000; 355: 1582–1587, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Volpe M, Rao M, Tritto C, Pisani A, Mele A, Enea I, Condorelli M. Transition from asymptomatic left ventricular dysfunction to congestive heart failure. J Card Fail 1995; 1(5)409–419, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Volpe M, Magri P, Rao M AE, Cangianiello S, De Luca N, Mele A F, Memoli B, Enea I, Rubattu S, Gigante B, Trimarco B, Condorelli M. Intrarenal determinants of sodium retention in mild heart failure. Hypertension 1997; 30: 168–176, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Magri P, Rao M AE, Cangianiello S, Bellizzi V, Russo R, Mele A LF, Andreucci M, Memoli B, De Luca N, Volpe M. Early impairment of renal hemodinamic reserve in patients with asyntomatic heart failure is restored by angiotensin II antagonism. Circulation 1998; 98: 2849–2854, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Volpe M, Tritto C, De Luca N, Mele A F, Lembo G, Rubattu S, Romano M, De Campora P, Enea I, Ricciardelli B, Trimarco B, Condorelli M. Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. J Clin Invest 1991; 88: 1481–1489, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Volpe M, Tritto C, DeLuca N, Rubattu S, Mele A, Lembo G, Enea I, De Campora P, Rendina P, Romano M, Trimarco B, Condorelli M. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure. Circulation 1992; 86: 1800–1809, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Volpe M, Tritto C, DeLuca N, Rubattu S, Rao M, Lamenza F, Mirante A, Enea I, Rendina V, Mele A, Trimarco B, Condorelli M. Abnormalities of sodium handing and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation 1993; 88: 1620–1627, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Volpe M, Lembo G, De Luca N, Lamenza F, Tritto C, Ricciardelli B, Molaro M, De Campora P, Condorelli G, Rendina V. Abnormal hormonal and renal responses to saline load in hypertensive patients with parental history of cardiovascular accidents. Circulation 1991; 84: 92–100, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Rubattu S, Volpe M. The atrial natriuretic peptide: a changing view. J Hypertens 2001; 19: 1923–1931, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Levin E R, Gardner D G, Samson W K. Natriuretic peptides. N Engl J Med 1998; 339: 321–328, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Briguori C, Betocchi S, Manganelli F, Gigante B, Losi M A, Ciampi Q, Gottilla R, Violante A, Tocchetti C G, Volpe M, Chiariello M. Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy. Eur Heart J 2001; 22(15)1328–1336, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Krum H, Roecker E B, Mohacsi P, Rouleau J L, Tendera M, Coats A J, Katus H A, Fowler M B, Packer M. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA 2003; 289(6)712–718, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Flather M D, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp‐Pedersen C, Ball S, Pogue J, Moye L, Braunwald for the ACE‐Inhibitor Myocardial Infarction Collaborative Group E. Long‐term ACE‐inhibitor therapy in patients with heart failure or left‐ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355: 1575–1581, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Garg R, Yusuf for the Collaborative Group on ACE Inhibitor Trials S. Overview of randomized trials of angiotensin‐converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA May 10, 1995; 273(18)1450–1456, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Cohn J N, Tagnoni for the Valsartan Heart Failure Trial Investigators G. A randomized trial of the angiotensin II receptor blocker Valsartan in congestive heart failure (Val‐HeFT). N Engl J Med 2001; 345: 1667–1675, [CROSSREF], [CSA]
   Google Scholar
• Ruschitzka F T. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat vs. enalapril randomized trial of utility in reducing events (OVERTURE). Curr Hypertens Rep Feb, 2003; 5(1)57–58, [PUBMED], [INFOTRIEVE]
   Google Scholar